Correlation Between Magna International and Citius Oncology,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Magna International and Citius Oncology, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Magna International and Citius Oncology, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Magna International and Citius Oncology,, you can compare the effects of market volatilities on Magna International and Citius Oncology, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Magna International with a short position of Citius Oncology,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Magna International and Citius Oncology,.

Diversification Opportunities for Magna International and Citius Oncology,

-0.35
  Correlation Coefficient

Very good diversification

The 3 months correlation between Magna and Citius is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Magna International and Citius Oncology, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Citius Oncology, and Magna International is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Magna International are associated (or correlated) with Citius Oncology,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Citius Oncology, has no effect on the direction of Magna International i.e., Magna International and Citius Oncology, go up and down completely randomly.

Pair Corralation between Magna International and Citius Oncology,

Considering the 90-day investment horizon Magna International is expected to generate 0.14 times more return on investment than Citius Oncology,. However, Magna International is 7.0 times less risky than Citius Oncology,. It trades about -0.04 of its potential returns per unit of risk. Citius Oncology, is currently generating about -0.15 per unit of risk. If you would invest  5,579  in Magna International on September 14, 2024 and sell it today you would lose (1,158) from holding Magna International or give up 20.76% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy35.34%
ValuesDaily Returns

Magna International  vs.  Citius Oncology,

 Performance 
       Timeline  
Magna International 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Magna International are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating technical and fundamental indicators, Magna International sustained solid returns over the last few months and may actually be approaching a breakup point.
Citius Oncology, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Citius Oncology, has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unfluctuating performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Magna International and Citius Oncology, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Magna International and Citius Oncology,

The main advantage of trading using opposite Magna International and Citius Oncology, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Magna International position performs unexpectedly, Citius Oncology, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Citius Oncology, will offset losses from the drop in Citius Oncology,'s long position.
The idea behind Magna International and Citius Oncology, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format